Related Experiment Video
Updated: Jul 19, 2026

Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing
Published on: December 3, 2019
Differential expression of BDNF mRNA splice variants in mouse brain and immune cells
Niels Kruse1, Seray Cetin, Andrew Chan
1Institute for Multiple Sclerosis Research, Medical Faculty of University of Göttingen and Gemeinnützige Hertie-Stiftung, Waldweg 33, 37073 Göttingen, Germany.
Abstract:
For the neurotrophin BDNF several splice variants were recently described. We analyzed the expression of mBDNF mRNA splice variants in cells of the immune system in comparison to the central nervous system (CNS). Whereas all splice variants are expressed in the CNS, only mBDNF 3 mRNA could be detected in primary and secondary lymphoid organs as well as in purified T cells and macrophages. After activation, only mBDNF 3 mRNA expression was upregulated in T cells without the additional appearance of other mBDNF splice variants. Therefore, mBDNF mRNA is differentially regulated in the CNS and the immune system opening the possibility of specific manipulation of mBDNF expression in immune cells without globally affecting mBDNF in the CNS.
Insights
Researchers found that only one brain-derived neurotrophic factor (BDNF) splice variant, mBDNF 3, is expressed in immune cells. This specific expression in immune cells, unlike the central nervous system (CNS), allows for targeted manipulation of BDNF in immunity.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Brain-derived neurotrophic factor (BDNF) is crucial for neuronal development and function.
- Several splice variants of BDNF mRNA have been identified.
- The expression patterns of BDNF splice variants in the immune system are not well understood.
Purpose of the Study:
- To investigate the expression of different BDNF mRNA splice variants in immune cells.
- To compare BDNF splice variant expression in immune cells with that in the central nervous system (CNS).
- To explore the potential for targeted manipulation of BDNF in immune responses.
Main Methods:
- Analysis of mBDNF mRNA splice variant expression.
- Comparison between immune cells (lymphoid organs, T cells, macrophages) and CNS tissue.
- Assessment of mBDNF mRNA expression changes in activated T cells.
Main Results:
- All mBDNF mRNA splice variants are expressed in the CNS.
- Only mBDNF 3 mRNA variant was detected in primary and secondary lymphoid organs, T cells, and macrophages.
- T cell activation upregulated mBDNF 3 mRNA expression without inducing other variants.
Conclusions:
- mBDNF mRNA is differentially regulated in the CNS and the immune system.
- The specific expression of mBDNF 3 in immune cells offers a potential target for therapeutic intervention.
- Immune cell BDNF expression can be modulated without affecting global BDNF levels in the CNS.

